冠心病患者对抗血栓治疗的知识,态度和实践
Yingqiang Du1, Xingyou Cai1, Xin Hong1
1Department of Cardiology, Suzhou Municipal Hospital, Gusu School, the Affiliated Suzhou Hospital of Nanjing Medical University, Nanjing Medical University, Suzhou, Jiangsu Province, 215000, China.
BMC public health
|February 10, 2025
概括
冠状动脉病患者的态度和实践良好,但对抗血栓治疗的知识中等. 提高患者知识,特别是在农村地区,对于更好的坚持和结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 患者教育 患者教育
背景情况:
- 抗血栓治疗对于治疗冠状动脉心脏病 (CHD) 是至关重要的.
- 了解患者的知识,态度和实践 (KAP) 对有效的治疗坚持至关重要.
- 这项研究评估了KAP在心血管疾病患者的抗血栓治疗方面.
研究的目的:
- 评估冠心病患者关于抗血栓治疗的知识,态度和实践 (KAP).
- 在这个患者群体中确定影响KAP和自我效能的因素.
- 为改善抗血栓治疗的坚持提供有针对性的干预信息.
主要方法:
- 一项涉及639名心血管疾病患者的横截面研究.
- 通过调查问卷收集的数据评估了人口统计信息,KAP分数和使用适当药物使用量表 (SEAMS) 的自我有效性.
- 统计分析以确定KAP和自我有效性的相关性和预测因素.
主要成果:
- 中位数的KAP得分表明了适当的态度和实践,但只有适度的知识,特别是关于抗血栓剂的剂量,管理,重要性和副作用.
- 大约70%的患者对剂量/管理有错误的了解,40%的人对治疗的重要性/副作用无知.
- 较低的实践分数与农村居住,较低的态度分数和自我效能低下有关. 低自我效能与体重不足,高家庭收入,短暂的病史和低态度得分有关.
结论:
- 冠状动脉疾病患者表现出对抗血栓治疗的知识差距,尽管积极的态度和做法.
- 干预措施应优先提高知识,特别是农村人口,以提高坚持.
- 改善患者的KAP可以促进更好的医生-患者沟通和治疗结果.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
461
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
461
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
01:23Assessment of the Cardiovascular System I: Subjective Data
263
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
263
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
131
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
131